[ed. note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, is a longtime medical writer (not a doctor) who writes for us a couple times a month about health issues, marketing, and trends. He does not typically focus on specific investment opportunities, but has agreed to our trading restrictions… as with all of our […]
Articles
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
That ad has been running for a long time now, but it's Editas... covered here most recently: https://www.stockgumshoe...
Speaking of cancer treatments..................................................... "One drop of company’s breakthro...
Looking @ your progress spreadsheet, to be fair to Dylan Jovine, he recommended RSH last fall when it was around $16-$17...